1. Home
  2. PD vs MNKD Comparison

PD vs MNKD Comparison

Compare PD & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PD
  • MNKD
  • Stock Information
  • Founded
  • PD 2009
  • MNKD 1991
  • Country
  • PD United States
  • MNKD United States
  • Employees
  • PD N/A
  • MNKD N/A
  • Industry
  • PD Computer Software: Prepackaged Software
  • MNKD Biotechnology: Pharmaceutical Preparations
  • Sector
  • PD Technology
  • MNKD Health Care
  • Exchange
  • PD Nasdaq
  • MNKD Nasdaq
  • Market Cap
  • PD 1.4B
  • MNKD 1.4B
  • IPO Year
  • PD 2019
  • MNKD 2004
  • Fundamental
  • Price
  • PD $14.26
  • MNKD $4.15
  • Analyst Decision
  • PD Buy
  • MNKD Strong Buy
  • Analyst Count
  • PD 12
  • MNKD 5
  • Target Price
  • PD $19.67
  • MNKD $9.40
  • AVG Volume (30 Days)
  • PD 1.2M
  • MNKD 1.9M
  • Earning Date
  • PD 05-29-2025
  • MNKD 05-08-2025
  • Dividend Yield
  • PD N/A
  • MNKD N/A
  • EPS Growth
  • PD N/A
  • MNKD 228.27
  • EPS
  • PD N/A
  • MNKD 0.10
  • Revenue
  • PD $476,132,000.00
  • MNKD $297,595,000.00
  • Revenue This Year
  • PD $10.97
  • MNKD $14.36
  • Revenue Next Year
  • PD $9.15
  • MNKD $13.36
  • P/E Ratio
  • PD N/A
  • MNKD $40.01
  • Revenue Growth
  • PD 8.55
  • MNKD 32.50
  • 52 Week Low
  • PD $13.94
  • MNKD $4.05
  • 52 Week High
  • PD $23.12
  • MNKD $7.63
  • Technical
  • Relative Strength Index (RSI)
  • PD 33.32
  • MNKD 37.04
  • Support Level
  • PD $15.68
  • MNKD $4.07
  • Resistance Level
  • PD $16.33
  • MNKD $4.25
  • Average True Range (ATR)
  • PD 0.46
  • MNKD 0.16
  • MACD
  • PD -0.11
  • MNKD -0.03
  • Stochastic Oscillator
  • PD 9.57
  • MNKD 12.82

About PD PagerDuty Inc.

PagerDuty Inc is a digital operations management platform that manages urgent and mission-critical work for a modern, digital business. Its PagerDuty Operations Cloud combines artificial intelligence (AI) operations (AIOps), automation, customer service operations, and incident management with a generative AI assistant to create a flexible, resilient, and scalable platform to protect revenue and improve customer experience, improve operational efficiency, and mitigate the risk of operational failures. The company generates revenue predominantly from cloud-hosted software subscription fees and term-license software subscription fees. Geographically, the firm derives a majority of its revenue from the United States and the rest from International markets.

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

Share on Social Networks: